| 注册
首页|期刊导航|临床与病理杂志|干扰素治疗慢性乙型肝炎疗效预测因素的研究进展

干扰素治疗慢性乙型肝炎疗效预测因素的研究进展

王坤(综述) 朱传龙(审校)

临床与病理杂志Issue(6):1157-1163,7.
临床与病理杂志Issue(6):1157-1163,7.DOI:10.3978/j.issn.2095-6959.2015.06.055

干扰素治疗慢性乙型肝炎疗效预测因素的研究进展

Research progress on predictors of interferon treatment in patients with chronic hepatitis B

王坤(综述) 1朱传龙(审校)2

作者信息

  • 1. 安徽医科大学附属安徽省立医院感染病科,合肥 230001
  • 2. 南京医科大学第一附属医院感染病科,南京 210029
  • 折叠

摘要

Abstract

Interferon-alpha (IFN-α) remains as one of the first-line drugs used in chronic hepatitis B treatment. IFN-α has several advantages, such as ifnite course of therapy and long-term beneift. However, clinical application of IFN-αis still limited due to its side effect and ineffcient antiviral ability. hTerefore, it is very important for physicians to learn how to predict the effcacy of IFN-α treatment in patients with chronic hepatitis B. In this review, we focus on some various factors which can affect the effcacy of IFN-α treatment, hoping can provide reference for the clinicians.

关键词

干扰素/慢性乙型肝炎/疗效

Key words

interferon-alpha (IFN-α)/chronic hepatitis B/efectiveness

引用本文复制引用

王坤(综述),朱传龙(审校)..干扰素治疗慢性乙型肝炎疗效预测因素的研究进展[J].临床与病理杂志,2015,(6):1157-1163,7.

基金项目

国家自然科学基金资助项目(81271713);安徽省第五批优秀青年科技基金滚动支持项目(1308085JGD09)。@@@@Tis work was supported by National Natural Science Foundation of China (81271713), Science and Technological Fund of Anhui Province for Outstanding Youth (1308085JGD09), P. R. China (81271713)

临床与病理杂志

OACSTPCD

1673-2588

访问量0
|
下载量0
段落导航相关论文